Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $2.14
- Average 1Y price target
- $2.87+34.11%
- Agreement
- Low
Analysts agreement range is spread more than 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall2
- DCF3
- Return on equity5
- Return on assets1
- Debt / equity1
- P/E1
- P/B1
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 0 | — |
| Last quarter | 0 | — |
| Last year | 0 | — |
| All time | 5 | $2.47 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 29, 2026 | UBS | maintain | Neutral | Neutral |
| Apr 29, 2026 | Keybanc | downgrade | Overweight | Sector Weight |
| Apr 1, 2026 | UBS | maintain | Neutral | Neutral |
| Mar 26, 2025 | Wedbush | maintain | Neutral | Neutral |
| Sep 4, 2024 | Wedbush | downgrade | Outperform | Neutral |
| Aug 6, 2024 | Craig-Hallum | maintain | Hold | Hold |
| May 8, 2024 | Wedbush | maintain | Outperform | Outperform |
| Mar 21, 2024 | Roth MKM | maintain | Buy | Buy |
| Mar 13, 2024 | Wedbush | maintain | Outperform | Outperform |
| Mar 13, 2024 | Roth MKM | upgrade | Neutral | Buy |
| Mar 13, 2024 | Craig-Hallum | maintain | Hold | Hold |
| Mar 7, 2024 | Roth MKM | maintain | Neutral | Neutral |
| Jan 24, 2024 | Wedbush | maintain | Outperform | Outperform |
| Jan 24, 2024 | Keybanc | maintain | Overweight | Overweight |
| Nov 13, 2023 | Oppenheimer | downgrade | Outperform | Perform |
| Nov 10, 2023 | Wedbush | maintain | Outperform | Outperform |
| Nov 10, 2023 | Keybanc | maintain | Overweight | Overweight |
| Nov 10, 2023 | Craig-Hallum | downgrade | Buy | Hold |
| Aug 25, 2023 | Oppenheimer | maintain | Outperform | Outperform |
| Aug 10, 2023 | Wedbush | maintain | Outperform | Outperform |
| Apr 14, 2023 | Wedbush | maintain | Outperform | Outperform |
| Mar 21, 2023 | UBS | maintain | Neutral | Neutral |
| Feb 1, 2023 | Keybanc | maintain | Overweight | Overweight |
| Jan 12, 2023 | Keybanc | maintain | Overweight | Overweight |
| Nov 10, 2022 | Craig-Hallum | upgrade | Hold | Buy |
| Sep 20, 2022 | Wedbush | maintain | Outperform | Outperform |
| Sep 20, 2022 | Keybanc | maintain | Overweight | Overweight |
| Mar 28, 2022 | Keybanc | maintain | Overweight | Overweight |
| Mar 2, 2022 | Roth Capital | downgrade | Buy | Neutral |
| Mar 2, 2022 | Keybanc | maintain | Overweight | Overweight |
| Dec 14, 2021 | Wedbush | maintain | Outperform | Outperform |
| Dec 14, 2021 | Keybanc | maintain | Overweight | Overweight |
| Nov 10, 2021 | UBS | downgrade | Buy | Neutral |
| Nov 10, 2021 | Truist Securities | downgrade | Buy | Hold |
| Nov 10, 2021 | Raymond James | downgrade | Outperform | Market Perform |
| Nov 10, 2021 | Keybanc | maintain | Overweight | Overweight |
| Nov 10, 2021 | B. Riley Securities | downgrade | Buy | Neutral |
| Nov 8, 2021 | B of A Securities | downgrade | Buy | Underperform |
| Oct 4, 2021 | Keybanc | maintain | Overweight | Overweight |
| Sep 28, 2021 | Craig-Hallum | downgrade | Buy | Hold |